Wilson, DO A. PCSK9 Inhibitors, The Most Significant Advance in Lipid Lowering Therapy Since Statins? A Literature Review. OFP [Internet]. 2019 Jul. 13 [cited 2024 Apr. 26];11(4). Available from: https://ofpjournal.com/index.php/ofp/article/view/585